Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the United States. The company's lead program is the development of Endoxifen, an active metabolite of tamoxifen which is in Phase II studies to treat and prevent breast cancer. It is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and Chimeric Antigen Receptor T-cell therapies, directly to the site of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2009 and is headquartered in Seattle, Washington. Show More...
-
Website http://atossatherapeutics.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.78 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -32.4 -68.4 -73.8 -126.0 -109.8 -99.72 -25.92 -10.97 -5.5 -2.03 -1.73 Dividends USD Payout Ratio % * Shares Mil 1.0 4.0 8.0 9.0 Book Value Per Share * USD 72.11 111.83 111.62 49.93 17.16 0.97 1.81 1.64 1.18 Free Cash Flow Per Share * USD -58.32 -103.57 -87.44 -86.65 -42.22 -12.15 -2.57 -1.17 Return on Assets % -223.02 -102.64 -114.52 -123.32 -175.04 -122.62 -173.71 -230.17 -131.55 -98.14 Financial Leverage (Average) 1.97 1.32 1.13 1.24 1.67 1.34 1.18 1.33 1.1 1.08 Return on Equity % -972.57 -150.84 -136.71 -145.85 -238.07 -186.26 -213.05 -290.71 -157.0 -106.04 Return on Invested Capital % -360.6 -150.52 -136.71 -143.9 -238.07 -186.26 -209.21 -290.71 -156.29 -105.6 Interest Coverage -117.91 -190.32 -420.91 -928.54 -41.13 Current Ratio 0.010 1.95 1.21 5.27 4.1 1.72 3.11 6.45 3.96 10.83 12.85 Quick Ratio 0.010 1.26 1.13 4.61 3.97 1.49 2.89 6.18 3.74 10.07 11.11 Debt/Equity 0.010